Engineered models of tumor metastasis with immune cell contributions

• Main Authors: Pamela L. Graney, Daniel Naveed Tavakol, Alan Chramiec, Kacey Ronaldson-Bouchard, Gordana Vunjak-Novakovic
• Format: Article
• Language: English
• Published: Elsevier 2021-03-01
• Series: iScience
• Subjects: components of the immune system; bioengineering; cancer; biochemical assay
• Online Access: http://www.sciencedirect.com/science/article/pii/S2589004221001474

Summary: Most cancer deaths are due to tumor metastasis rather than the primary tumor. Metastasis is a highly complex and dynamic process that requires orchestration of signaling between the tumor, its local environment, distant tissue sites, and immune system. Animal models of cancer metastasis provide the necessary systemic environment but lack control over factors that regulate cancer progression and often do not recapitulate the properties of human cancers. Bioengineered “organs-on-a-chip” that incorporate the primary tumor, metastatic tissue targets, and microfluidic perfusion are now emerging as quantitative human models of tumor metastasis. The ability of these systems to model tumor metastasis in individualized, patient-specific settings makes them uniquely suitable for studies of cancer biology and developmental testing of new treatments. In this review, we focus on human multi-organ platforms that incorporate circulating and tissue-resident immune cells in studies of tumor metastasis.